| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711669 | Annals of Allergy, Asthma & Immunology | 2018 | 20 Pages |
Abstract
Treatment with 12 SQ-HDM consistently improved symptoms and was well tolerated in relevant subgroups of subjects with HDM AR/C. Local application site reactions to 12 SQ-HDM were typically mild to moderate and transient.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
David I. MD, Joerg MD, Harold S. MD, Jose A. MD, Gordon L. MD, Susan PharmD, Dorte PhD, Bodil MSc, Hendrik MD, PhD,